TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis
2009;48:1201-10.
1.574 Darley ES et al. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother
2004;53:928-35.
1.575 Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005;
19:853-61.
1.576 Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005;
19:853-61.
1.577 Babcock HM et al. Postarthroscopy surgical site infections: review of the literature. Clin Infect Dis
2002;34:65-71.
1.578 Bejon P et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of
reimplantation microbiology. J Antimicrob Chemother 2010;65:569-75.
1.579 Berbari EF et al. Outcome of prosthetic joint infections in patients with rheumatoid arthritis: the impact
of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006;42:216-23.
1.580 Marculescu CE et al. Outcome of prosthetic joint infections treated with debridement and retention of
components. Clin Infect Dis 2006;42:471-8.
1.581 Bernard L et al. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother
2004;53:127-9.
1.582 Byren I et al. One hundred and twelve infected arthroplasties treated with ‗DAIR‘ (debridement, antibiotics
and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009;63:
1264-71.
1.583 Del Pozo JL et al. Infection associated with prosthetic joints. N Engl J Med 2009;361:787-94.
1.584 Anguita-Alonso P et al. Prosthetic joint infection. Expert Rev Anti Infect Ther 2005;3:797-804.
1.585 Zimmerli W et al. Prosthetic joint infections. N Engl J Med 2004;351:1645-54.
1.586 Sia IG et al. Prosthetic joint infections. Infect Dis Clin North Am 2005;19:885-914.
1.587 Fernandez Sampedro M et al. Infections associated with long-term prosthetic devices. Infect Dis Clin
North Am 2007;21:785-819.
1.588 Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin
Infect Dis 2001;33(suppl. 2):S94-106.
1.589 Darley ES et al. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother
2004;53:928-35.
1.590 Aboltins CA et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis
retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007;13:586-91.
1.591 Berbari EF et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007;45:1113-9.
1.592 El Helou OC et al. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy
superior to monotherapy? Clin Infect Dis 2008;47:903-9.
1.593 Martínez-Pastor JC et al. Outcome of acute prosthetic joint infections due to Gram-negative bacilli
treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother
2009;53:4772-7.
1.594 Hsieh PH et al. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin
Infect Dis 2009;49:1036-43.
1.595 Samuel JR et al. Prosthetic joint infections: single versus combination therapy. J Antimicrob Chemother
2010;65:18-23.
1.596 Nguyen S et al. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole
combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect 2009;15:
1163-9.
1.597 Stein A et al. Ambulatory treatment of multidrug resistant Staphylococcus-infected orthopedic implants
with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother
1998;42:3086-91.
1.598 Zimmerli W et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections.
A randomized controlled trial. J Am Med Assoc 1998;279:1537-41.
1.599 Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents
against tumor necrosis factor alpha. Morb Mortal Wkly Rep 2004;53:683-6.
1.600 Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect
Dis 2008;8:601-11.
1.601 Wallis RS. Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis 2009;22:
403-9.
1.602 Bongartz T et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections
and malignancies. Systematic review and meta-analysis of rare harmful effects in randomized controlled
trials. J Am Med Assoc 2006;295:2275-85.
1.603 Zimmermann B et al. Septic bursitis. Semin Arthritis Rheum 1995;24:391-410.
1.604 Small LN et al. Suppurative tenosynovytis and septic bursitis. Infect Dis Clin North Am 2005;19:
991-2005.
1.605 Nicolle LE et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of
asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.
1.606 Colgan R et al. Asymptomatic bacteriuria in adults. Am Fam Physician 2006;74:985-90.
1.607 Schnarr J et al. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur
J Clin Invest 2008;38(suppl. 2):50-7.
1.608 U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults: U.S. Preventive
Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008;149:43-7.
1.609 Hooton TM et al. Diagnosis, prevention and treatment of catheter-associated urinary tract infection in
adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America.
Clin Infect Dis 2010;50:625-63.
1.610 Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med
2002;113(suppl. 1A):67S-79S.
1.611 Warren JW et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and
acute pyelonephritis in women. Clin Infect Dis 1999;29:745-58.
1.612 Brown P et al. Acute pyelonephritis among adults. Cost of illness and considerations for the economic
evaluation of therapy. Pharmacoeconomics 2005;23:1123-42.
1.613 Schnarr J et al. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur
J Clin Invest 2008;38(suppl. 2):50-7.
1.614 Wagenlehner FM et al. Current challenges in the treatment of complicated urinary tract infections and
prostatitis. Clin Microbiol Infect 2006;12(suppl. 3):67-80.